Monocyte to High-Density Lipoprotein Cholesterol Ratio Decreased in Patients with Psoriasis Treated with Ixekizumab
Revista de Investigación Clínica · 2023
DOI: 10.24875/ric.23000085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista de Investigación Clínica, 2023. Verfasst von Funda Tamer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Gazi University School of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Psoriasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Gazi University School of Medicine, Ankara, Turkey.
Zitieren
APA
Tamer, F., Kucukhemek, F., & Gulekon, A. (2023). Monocyte to High-Density Lipoprotein Cholesterol Ratio Decreased in Patients with Psoriasis Treated with Ixekizumab. Revista de Investigación Clínica. https://doi.org/10.24875/ric.23000085
Vancouver
Tamer F, Kucukhemek F, Gulekon A. Monocyte to High-Density Lipoprotein Cholesterol Ratio Decreased in Patients with Psoriasis Treated with Ixekizumab. Revista de Investigación Clínica. 2023. doi:10.24875/ric.23000085
BibTeX
@article{Tamer2023,
author = {Tamer, Funda and Kucukhemek, Fahrettin and Gulekon, Ayla},
title = {Monocyte to High-Density Lipoprotein Cholesterol Ratio Decreased in Patients with Psoriasis Treated with Ixekizumab},
journal = {Revista de Investigación Clínica},
year = {2023},
doi = {10.24875/ric.23000085}
}
EUVIMED